203 related articles for article (PubMed ID: 9699707)
1. Melatonin for the treatment of sleep disturbances in major depressive disorder.
Dolberg OT; Hirschmann S; Grunhaus L
Am J Psychiatry; 1998 Aug; 155(8):1119-21. PubMed ID: 9699707
[TBL] [Abstract][Full Text] [Related]
2. Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder.
Fava M; McCall WV; Krystal A; Wessel T; Rubens R; Caron J; Amato D; Roth T
Biol Psychiatry; 2006 Jun; 59(11):1052-60. PubMed ID: 16581036
[TBL] [Abstract][Full Text] [Related]
3. A randomized double-blind placebo-controlled trial of treatment as usual plus exogenous slow-release melatonin (6 mg) or placebo for sleep disturbance and depressed mood.
Serfaty MA; Osborne D; Buszewicz MJ; Blizard R; Raven PW
Int Clin Psychopharmacol; 2010 May; 25(3):132-42. PubMed ID: 20195158
[TBL] [Abstract][Full Text] [Related]
4. Preliminary randomized double-blind placebo-controlled trial of tryptophan combined with fluoxetine to treat major depressive disorder: antidepressant and hypnotic effects.
Levitan RD; Shen JH; Jindal R; Driver HS; Kennedy SH; Shapiro CM
J Psychiatry Neurosci; 2000 Sep; 25(4):337-46. PubMed ID: 11022398
[TBL] [Abstract][Full Text] [Related]
5. A comparative trial of fluoxetine and amitriptyline in patients with major depressive disorder.
Feighner JP
J Clin Psychiatry; 1985 Sep; 46(9):369-72. PubMed ID: 3897204
[TBL] [Abstract][Full Text] [Related]
6. Effect of fluoxetine on dexamethasone-induced growth hormone release in depression: a double-blind, placebo-controlled study.
Thakore JH; Dinan TG
Am J Psychiatry; 1995 Apr; 152(4):616-8. PubMed ID: 7694914
[TBL] [Abstract][Full Text] [Related]
7. Effect of pindolol in hastening response to fluoxetine in the treatment of major depression: a double-blind, placebo-controlled trial.
Berman RM; Darnell AM; Miller HL; Anand A; Charney DS
Am J Psychiatry; 1997 Jan; 154(1):37-43. PubMed ID: 8988956
[TBL] [Abstract][Full Text] [Related]
8. A double-blind controlled clinical trial of fluoxetine and amitriptyline in the treatment of outpatients with major depressive disorder.
Chouinard G
J Clin Psychiatry; 1985 Mar; 46(3 Pt 2):32-7. PubMed ID: 3882679
[TBL] [Abstract][Full Text] [Related]
9. Double-blind comparison of bupropion and fluoxetine in depressed outpatients.
Feighner JP; Gardner EA; Johnston JA; Batey SR; Khayrallah MA; Ascher JA; Lineberry CG
J Clin Psychiatry; 1991 Aug; 52(8):329-35. PubMed ID: 1907963
[TBL] [Abstract][Full Text] [Related]
10. A review of multicenter controlled studies of fluoxetine vs. imipramine and placebo in outpatients with major depressive disorder.
Stark P; Hardison CD
J Clin Psychiatry; 1985 Mar; 46(3 Pt 2):53-8. PubMed ID: 3882682
[TBL] [Abstract][Full Text] [Related]
11. Fluoxetine versus trazodone: efficacy and activating-sedating effects.
Beasley CM; Dornseif BE; Pultz JA; Bosomworth JC; Sayler ME
J Clin Psychiatry; 1991 Jul; 52(7):294-9. PubMed ID: 2071559
[TBL] [Abstract][Full Text] [Related]
12. A comparison of fluoxetine, imipramine, and placebo in patients with major depressive disorder.
Cohn JB; Wilcox C
J Clin Psychiatry; 1985 Mar; 46(3 Pt 2):26-31. PubMed ID: 3882677
[TBL] [Abstract][Full Text] [Related]
13. Coadministration of melatonin and fluoxetine does not improve the 3-month outcome following ECT.
Grunhaus L; Hirschman S; Dolberg OT; Schreiber S; Dannon PN
J ECT; 2001 Jun; 17(2):124-8. PubMed ID: 11417923
[TBL] [Abstract][Full Text] [Related]
14. Fluoxetine versus trazodone in the treatment of outpatients with major depression.
Debus JR; Rush AJ; Himmel C; Tyler D; Polatin P; Weissenburger J
J Clin Psychiatry; 1988 Nov; 49(11):422-6. PubMed ID: 3053668
[TBL] [Abstract][Full Text] [Related]
15. Mood, major depression, and fluoxetine response in cigarette smokers.
Dalack GW; Glassman AH; Rivelli S; Covey L; Stetner F
Am J Psychiatry; 1995 Mar; 152(3):398-403. PubMed ID: 7864266
[TBL] [Abstract][Full Text] [Related]
16. A fixed-dose clinical trial of fluoxetine in outpatients with major depression.
Fabre LF; Putman HP
J Clin Psychiatry; 1987 Oct; 48(10):406-8. PubMed ID: 3312176
[TBL] [Abstract][Full Text] [Related]
17. Pattern analysis of antidepressant response to fluoxetine.
Fieve RR; Goodnick PJ; Peselow ED; Barouche F; Schlegel A
J Clin Psychiatry; 1986 Nov; 47(11):560-2. PubMed ID: 3533909
[TBL] [Abstract][Full Text] [Related]
18. A randomized, double-blind, and placebo-controlled trial of quetiapine augmentation of fluoxetine in major depressive disorder.
Garakani A; Martinez JM; Marcus S; Weaver J; Rickels K; Fava M; Hirschowitz J
Int Clin Psychopharmacol; 2008 Sep; 23(5):269-75. PubMed ID: 18703936
[TBL] [Abstract][Full Text] [Related]
19. A randomized double-blind study of fluoxetine versus placebo in the treatment of dysthymia.
Hellerstein DJ; Yanowitch P; Rosenthal J; Samstag LW; Maurer M; Kasch K; Burrows L; Poster M; Cantillon M; Winston A
Am J Psychiatry; 1993 Aug; 150(8):1169-75. PubMed ID: 8328559
[TBL] [Abstract][Full Text] [Related]
20. Gepirone extended-release: new evidence for efficacy in the treatment of major depressive disorder.
Feiger AD; Heiser JF; Shrivastava RK; Weiss KJ; Smith WT; Sitsen JM; Gibertini M
J Clin Psychiatry; 2003 Mar; 64(3):243-9. PubMed ID: 12716264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
